Xin‐an Lu

Efficacy and safety of anti-CD19 CAR T-cell therapy in 110 patients with B-cell acute lymphoblastic leukemia with high-risk features

Xian Zhang, Xin‐an Lu, Junfang Yang et al. · Blood Advances · 2020 · 206 citations · Full text

Hematological Malignancy, Cell Therapy, Tp53 Mutation +15

Parallel Comparison of 4-1BB or CD28 Co-stimulated CD19-Targeted CAR-T Cells for B Cell Non-Hodgkin’s Lymphoma

Zhitao Ying, Ting He, Xiaopei Wang et al. · Molecular Therapy — Oncolytics · 2019 · 163 citations · Full text

Synthesis of Heparin Oligosaccharides

Jinq‐Chyi Lee, Xin‐an Lu, Suvarn S. Kulkarni et al. · Journal of the American Chemical Society · 2003 · 148 citations

Available Diacetone, Biosynthesis, Bioorganic Chemistry +12

Efficacy and Safety of CD28- or 4-1BB-Based CD19 CAR-T Cells in B Cell Acute Lymphoblastic Leukemia

Xiangyu Zhao, Junfang Yang, Xian Zhang et al. · Molecular Therapy — Oncolytics · 2020 · 117 citations · Full text

The CXCL12–CXCR4 Chemokine Pathway: A Novel Axis Regulates Lymphangiogenesis

Wei Zhuo, Lin Jia, Nan Song et al. · Clinical Cancer Research · 2012 · 107 citations